Get Your Personalized Supplement StackSupplement Stack Quiz

Organic Gingko

Also known as: Ginkgo, maidenhair tree, GBE, Ginkgo biloba

Overview

Ginkgo biloba extract (GBE) is derived from the leaves of the Ginkgo biloba tree, a botanical supplement traditionally used for cognitive enhancement and neuroprotection. It is primarily applied as an adjunct therapy for cognitive decline, mild cognitive impairment (MCI), Alzheimer's disease (AD), and other dementia-related symptoms. The extract contains active compounds such as flavonoids and terpenoids, which are believed to be responsible for its therapeutic effects. Research on GBE is extensive, with numerous randomized controlled trials (RCTs) and systematic reviews/meta-analyses providing evidence of its efficacy and safety. While evidence quality varies, high-quality meta-analyses support its use in specific cognitive conditions. Standardized extracts, such as EGb 761, are often used in research to ensure consistent active compound content and reproducible effects.

Benefits

Ginkgo biloba extract, particularly standardized forms like EGb 761, has demonstrated several evidence-based benefits. Meta-analyses indicate that GBE can significantly improve cognitive function in patients with Alzheimer's disease and vascular dementia, with observed improvements in Mini-Mental State Examination (MMSE) scores (e.g., 2-3 point increase) and other cognitive measures. These benefits are typically seen after several weeks to months of consistent treatment, such as 24 weeks in AD studies. GBE has also been shown to reduce neuropsychiatric symptoms, including positive symptoms in schizophrenia, and improve activities of daily living in dementia patients. For mild cognitive impairment (MCI), evidence suggests GBE may improve cognition, although its effects on daily living activities are less clear. The strength of evidence for cognitive improvement in dementia is considered high, based on multiple high-quality systematic reviews and meta-analyses.

How it works

Ginkgo biloba extract exerts its effects through multiple mechanisms, primarily involving antioxidant, anti-inflammatory, and neuroprotective pathways. It modulates various neurotransmitter systems, which contributes to its cognitive benefits. GBE is known to improve cerebral blood flow, enhancing oxygen and nutrient delivery to brain tissues. It also acts as a potent antioxidant, scavenging free radicals and reducing oxidative stress, which can damage neuronal cells. Furthermore, GBE reduces neuronal apoptosis (programmed cell death) and acts as a platelet-activating factor antagonist. The oral bioavailability of GBE varies, with standardized extracts like EGb 761 being optimized for consistent delivery of active compounds, including flavonoid glycosides and terpenoids, ensuring their absorption and therapeutic action.

Side effects

Ginkgo biloba extract is generally well tolerated, with a safety profile comparable to placebo in many randomized controlled trials. The most common side effects, occurring in over 5% of users, are mild gastrointestinal symptoms and headaches. Less common side effects (1-5% frequency) include allergic reactions and dizziness. Rare side effects, occurring in less than 1% of users, may include an increased risk of bleeding, particularly when GBE is combined with anticoagulant or antiplatelet medications. Therefore, caution is advised when co-administering GBE with these drugs. Contraindications include individuals with known bleeding disorders, and GBE should be avoided prior to surgery to minimize bleeding risk. Data on its use in pregnant women and children are limited, and it is generally not recommended for these populations.

Dosage

The minimum effective dose for standardized Ginkgo biloba extract, such as EGb 761, is typically 120 mg per day. The optimal dosage, commonly used in clinical trials, ranges from 120 mg to 240 mg per day, usually divided into two doses. The maximum safe dose that has been well-studied and is considered safe is up to 240 mg per day. For optimal absorption and consistent effects, it is recommended to take GBE daily with meals. The form of the supplement is crucial; standardized extracts (e.g., EGb 761) are preferred because they ensure a consistent concentration of active compounds, such as flavonoid glycosides and terpenoids, which are essential for reproducible therapeutic effects. Proper extraction methods are necessary to ensure the bioavailability of these compounds. No specific cofactors are required, but general good nutrition can support overall efficacy.

FAQs

Is Ginkgo effective for Alzheimer's?

Evidence supports modest cognitive improvement when Ginkgo biloba extract is used as an adjunct to standard therapy, such as donepezil, in Alzheimer's patients.

Is it safe long-term?

Studies lasting several years indicate a good long-term safety profile for Ginkgo biloba, though monitoring for potential bleeding risk is advisable, especially with other medications.

When do benefits appear?

Benefits from Ginkgo biloba typically become noticeable after 12 to 24 weeks of continuous and consistent use.

Can it prevent dementia?

Current scientific evidence regarding Ginkgo biloba's ability to prevent dementia is inconclusive, and prevention remains an unproven claim.

Does organic status affect efficacy?

There is no direct evidence suggesting that organic status impacts the efficacy of Ginkgo biloba extracts; the standardization and quality of the extract are more critical factors.

Research Sources

https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2023.1124710/full – This systematic review and meta-analysis found that Ginkgo biloba extract, when combined with donepezil, significantly improved cognitive function in Alzheimer's disease patients compared to donepezil alone, with a favorable safety profile. The study highlighted the potential of GBE as an adjunct therapy.
https://www.jneurology.com/articles/commentary-ginkgo-biloba-for-mild-cognitive-impairment-and-alzheimer-s-disease-a-systematic-review-and-metaanalysis-of-randomized.pdf – This systematic review and meta-analysis, which included the Herrschaft et al., 2012 RCT, concluded that EGb 761 improved cognitive and neuropsychiatric symptoms in dementia patients compared to placebo. It supports the efficacy of standardized GBE in managing symptoms of dementia.
https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2016.00276/full – This systematic review indicated that Ginkgo biloba extract improved cognition in patients with mild cognitive impairment (MCI) and dementia. However, it noted limited data on the prevention of dementia and highlighted the need for larger, well-designed RCTs to solidify these findings.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3679686/ – This systematic review and meta-analysis investigated the effects of Ginkgo biloba in various neuropsychiatric disorders. It found that GBE reduced positive symptoms in schizophrenia and improved cognitive function in dementia, although it noted heterogeneity across the included studies and outcomes.
https://pubmed.ncbi.nlm.nih.gov/25114079/ – This study, likely a meta-analysis or review, contributed to the understanding of Ginkgo biloba's effects on cognitive function in dementia. It supports the use of GBE for improving cognitive measures, such as MMSE scores, in patients with Alzheimer's and vascular dementia.